AC

ACHILLION PHARMACEUTICALS INC

  • CIK: 0001070336
  • EIN: 00-0000000
  • Business address: 300 GEORGE STREET, NEW HAVEN, Connecticut, 06511

Information

  • Mailing address
    300 GEORGE STREET, NEW HAVEN, Delaware, 06511
  • Phone
    203-624-7000
  • State location
    Connecticut
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About ACHILLION PHARMACEUTICALS INC

ACHILLION PHARMACEUTICALS INC (CIK: 0001070336) is an American company incorporated in the state of Connecticut. Head office is located at 300 GEORGE STREET, NEW HAVEN, Connecticut, 06511. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. ACHILLION PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
G1 EXECUTION SERVICES, LLC 0001136305 Jan-27-2020 10 percent owner
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 0001446179 Jan-27-2020 10 percent owner
SUSQUEHANNA SECURITIES, LLC 0001446580 Jan-27-2020 10 percent owner
Di Donato Brian 0001766498 Feb-11-2019 officer: Chief Financial Officer
Lantz Keri 0001762858 Jan-01-2019 officer: See Remarks
Firuta Paul E 0001602727 Sep-10-2018 officer: Chief Operating Officer
Zelenkofske Steven 0001578333 Aug-20-2018 officer: Chief Medical Officer
Gibney Anthony S 0001750132 Aug-15-2018 officer: Chief Business Officer
MANNING MARTHA E 0001227894 Feb-01-2016 officer: EVP, General Counsel
Barrish Joel C 0001662803 Jan-04-2016 officer: Chief Scientific Officer
Verwiel Frank 0001545794 Dec-14-2015 director
JOHNSON & JOHNSON 0000200406 Jul-01-2015 10 percent owner
Johnson & Johnson Innovation - JJDC, Inc. 0000924020 Jul-01-2015 10 percent owner
RA Capital Healthcare Fund LP 0001315082 Sep-30-2013 10 percent owner
RA CAPITAL MANAGEMENT, LLC 0001346824 Sep-30-2013 10 percent owner
Kolchinsky Peter 0001384859 Sep-30-2013 10 percent owner
QVT Fund V LP 0001543904 Jul-02-2013 10 percent owner
Apelian David 0001546842 May-28-2013 officer: EVP and Chief Medical Officer
QVT Associates GP LLC 0001290166 Feb-22-2013 10 percent owner
Graves Kurt 0001406337 Jun-11-2012 director
FISHERMAN JASON S 0001197540 Dec-12-2011 director
Quaker BioVentures II LP 0001497725 Feb-15-2011 10 percent owner
Kamdar Kim P. 0001535065 Jan-01-2011 10 percent owner
DOMAIN ASSOCIATES 0001020733 Oct-06-2010 10 percent owner
TREU JESSE I 0001013425 Aug-20-2010 10 percent owner
BLAIR JAMES C 0001024000 Aug-20-2010 10 percent owner
VITULLO NICOLE 0001196863 Aug-20-2010 10 percent owner
DOVEY BRIAN H 0001207786 Aug-20-2010 10 percent owner
SCHOEMAKER KATHLEEN K 0001207789 Aug-20-2010 10 percent owner
Halak Brian K 0001354718 Aug-20-2010 10 percent owner
DP VIII Associates, L.P. 0001465143 Aug-20-2010 10 percent owner
Domain Partners VIII, L.P. 0001465144 Aug-20-2010 10 percent owner
Truitt Joseph 0001452429 Jan-05-2009 officer: VP, Chief Commercial Officer
Liotta Dennis 0001448270 Dec-15-2008 director
INVESTOR GROWTH CAPITAL LTD 0001237710 Dec-04-2008 10 percent owner
STEINMETZ MICHAEL 0001166285 Sep-05-2008 10 percent owner
HENNER DENNIS 0001249153 Sep-05-2008 10 percent owner
GALAKATOS NICHOLAS 0001252522 Sep-05-2008 10 percent owner
LIPTAK ROBERT 0001252523 Sep-05-2008 10 percent owner
WHEELER KURT 0001252525 Sep-05-2008 10 percent owner
Simon Nicholas 0001431403 Sep-05-2008 director, 10 percent owner
Leiden Jeffrey 0001431408 Sep-05-2008 10 percent owner
Clarus Ventures II, LLC 0001431437 Sep-05-2008 10 percent owner
Clarus Ventures II GP, L.P. 0001431439 Sep-05-2008 10 percent owner
Clarus Lifesciences II, L.P. 0001431443 Sep-05-2008 10 percent owner
INVESTOR AB 0000889232 Aug-12-2008 10 percent owner
Moorin Jay 0001033508 Aug-12-2008 10 percent owner
SCHREIBER ALAIN 0001225149 Aug-12-2008 10 percent owner
ProQuest Investments IV, L.P. 0001431818 Aug-12-2008 10 percent owner
ProQuest Associates IV LLC 0001431819 Aug-12-2008 10 percent owner
FRASHIER GARY E 0001215914 Mar-31-2008 director
Olek Elizabeth A 0001419066 Dec-06-2007 officer: Vice President and CMO
WRIGHT DAVID P 0001206342 Aug-20-2007 director
VAN NOSTRAND ROBERT L 0001225198 Apr-27-2007 director
GILEAD SCIENCES INC 0000882095 Oct-25-2006 10 percent owner
SCHRODER VENTURES MANAGERS INC 0001002632 Oct-25-2006 10 percent owner
FORMELA JEAN FRANCOIS 0001030575 Oct-25-2006 director, 10 percent owner
ADVENT INTERNATIONAL CORP/MA 0001034196 Oct-25-2006 other: Member of group > 10%
SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1 0001076081 Oct-25-2006 10 percent owner
KISHBAUCH MICHAEL D 0001076979 Oct-25-2006 director, officer: CEO and President
ATLAS VENTURE FUND V LP 0001106910 Oct-25-2006 10 percent owner
ATLAS VENTURE PARALLEL FUND V-A C V 0001133758 Oct-25-2006 10 percent owner
ATLAS VENTURE ASSOCIATES V LP 0001133805 Oct-25-2006 10 percent owner
ATLAS VENTURE ENTREPRENEURS FUND V LP 0001133807 Oct-25-2006 10 percent owner
SCHRODER VENTURE MANAGERS LTD 0001161844 Oct-25-2006 10 percent owner
RYSER STEFAN 0001166284 Oct-25-2006 director
ADVENT PARTNERS HLS II LIMITED PARTNERSHIP 0001197521 Oct-25-2006 other: Member of group > 10%
ADVENT PARTNERS LIMITED PARTNERSHIP 0001197526 Oct-25-2006 other: Member of group > 10%
ADVENT INTERNATIONAL LIMITED PARTNERSHIP 0001197534 Oct-25-2006 other: Member of group > 10%
ADVENT HEALTHCARE & LIFE SCIENCES II LP 0001197633 Oct-25-2006 other: Member of group > 10%
ADVENT HEALTHCARE & LIFE SCIENCES II KG 0001197635 Oct-25-2006 other: Member of group > 10%
GARVEY JAMES M 0001207314 Oct-25-2006 director, 10 percent owner
GREY MICHAEL G 0001240122 Oct-25-2006 director
WHITE CHRISTOPHER A 0001283401 Oct-25-2006 director
SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment Scheme 0001320569 Oct-25-2006 10 percent owner
Schroder Ventures International Life Sciences Fund II Strategic Partners L.P. 0001320570 Oct-25-2006 10 percent owner
Schroder Ventures International Life Sciences Fund II L.P.3 0001320571 Oct-25-2006 10 percent owner
Schroder Ventures International Life Sciences Fund II L.P.2 0001320572 Oct-25-2006 10 percent owner
SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTD 0001320585 Oct-25-2006 10 percent owner
Scheer David 0001378585 Oct-25-2006 director
Shah Gautam 0001378586 Oct-25-2006 officer: SVP and Chief Compliance Ofc.
Pottage John C Jr 0001378587 Oct-25-2006 officer: SVP and Chief Medical Officer
Deshpande Milind 0001378588 Oct-25-2006 officer: SVP and Chief Scientific Ofc.
Fenton Mary Kay 0001378589 Oct-25-2006 officer: Vice President and CFO

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ACHILLION PHARMACEUTICALS INC

Filings Format Description Filed/Effective File/Film Number
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000354204-21-000634 (34 Act) Size: 18 KB		 Feb-16-2021

005-82163

21638147
SC 13G Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001140361-20-003382 (34 Act) Size: 62 KB		 Feb-14-2020

005-82163

20620753
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001493152-20-002369 (34 Act) Size: 164 KB		 Feb-14-2020

005-82163

20617416
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001258897-20-000748 (34 Act) Size: 51 KB		 Feb-12-2020

005-82163

20600955
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001104659-20-017780 (34 Act) Size: 13 KB		 Feb-12-2020

005-82163

20599889
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000834237-20-008677 (34 Act) Size: 12 KB		 Feb-10-2020

005-82163

20589347
15-12B Document

Notice of termination of registration of a class of securities under Section 12(b)

Acc-no: 0001193125-20-027298 (34 Act) Size: 10 KB		 Feb-07-2020

001-33095

20584461
EFFECT Document Acc-no: 9999999995-20-000204 (33 Act) Size: 1 KB Jan-31-2020

333-216197

20566839
EFFECT Document Acc-no: 9999999995-20-000202 (33 Act) Size: 1 KB Jan-31-2020

333-161375

20566838
EFFECT Document Acc-no: 9999999995-20-000203 (33 Act) Size: 1 KB Jan-31-2020

333-169460

20566836
EFFECT Document Acc-no: 9999999995-20-000201 (33 Act) Size: 1 KB Jan-31-2020

333-153870

20566832
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001104659-20-008815 ( Act) Size: 11 KB		 Jan-30-2020

3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001104659-20-008790 ( Act) Size: 15 KB		 Jan-30-2020

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000904454-20-000088 ( Act) Size: 28 KB		 Jan-29-2020

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001562180-20-000679 ( Act) Size: 8 KB		 Jan-29-2020

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001562180-20-000678 ( Act) Size: 13 KB		 Jan-29-2020

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001562180-20-000677 ( Act) Size: 20 KB		 Jan-29-2020

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001562180-20-000676 ( Act) Size: 25 KB		 Jan-29-2020

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001562180-20-000675 ( Act) Size: 22 KB		 Jan-29-2020

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001562180-20-000674 ( Act) Size: 14 KB		 Jan-29-2020

Recent 20 filings. View all ACHILLION PHARMACEUTICALS INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • ACHILLION PHARMACEUTICALS INC overview
  • ACHILLION PHARMACEUTICALS INC job
  • ACHILLION PHARMACEUTICALS INC stock
  • ACHILLION PHARMACEUTICALS INC ownership
  • ACHILLION PHARMACEUTICALS INC CEO
  • ACHILLION PHARMACEUTICALS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Contineum Therapeutics, Inc.
Update: Mar 16, 2024
Cuprina Holdings (Cayman) LTD
Update: Mar 08, 2024
APRINOIA Therapeutics Inc.
Update: Jan 27, 2024
Zhengye Biotechnology Holding Ltd
Update: Jan 10, 2024
Alto Neuroscience, Inc.
Update: Nov 28, 2023
Mural Oncology plc
Update: Nov 02, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1117 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3295 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 3268 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3240 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1640 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2938 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3062 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1644 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 1482 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by